Kings Point Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $961K | Buy |
11,710
+182
| +2% | +$14.3K | 0.08% | 104 |
|
|
2021
Q4 | $883K | Buy |
11,528
+731
| +7% | +$58.2K | 0.07% | 113 |
|
|
2021
Q3 | $811K | Buy |
10,797
+1,057
| +11% | +$80.4K | 0.07% | 116 |
|
|
2021
Q2 | $757K | Sell |
9,740
-889
| -8% | -$66.1K | 0.07% | 124 |
|
|
2021
Q1 | $782K | Buy |
10,629
+324
| +3% | +$23.9K | 0.08% | 112 |
|
|
2020
Q4 | $804K | Sell |
10,305
-3,512
| -25% | -$269K | 0.09% | 111 |
|
|
2020
Q3 | $1.09M | Buy |
13,817
+1,363
| +11% | +$107K | 0.14% | 95 |
|
|
2020
Q2 | $919K | Sell |
12,454
-643
| -5% | -$48.4K | 0.13% | 95 |
|
|
2020
Q1 | $962K | Buy |
13,097
+2,175
| +20% | +$171K | 0.17% | 87 |
|
|
2019
Q4 | $948K | Buy |
10,922
+332
| +3% | +$27.3K | 0.14% | 95 |
|
|
2019
Q3 | $851K | Buy |
10,590
+1,791
| +20% | +$144K | 0.14% | 94 |
|
|
2019
Q2 | $704K | Buy |
8,799
+3,660
| +71% | +$280K | 0.13% | 96 |
|
|
2019
Q1 | $408K | Hold |
5,139
| – | – | 0.08% | 106 |
|
|
2018
Q4 | $375K | Hold |
5,139
| – | – | 0.08% | 107 |
|
|
2018
Q3 | $348K | Hold |
5,139
| – | – | 0.06% | 127 |
|
|
2018
Q2 | $298K | Hold |
5,139
| – | – | 0.06% | 131 |
|
|
2018
Q1 | $267K | Sell |
5,139
-184
| -3% | -$9.94K | 0.05% | 134 |
|
|
2017
Q4 | $286K | Sell |
5,323
-58,165
| -92% | -$3.22M | 0.06% | 127 |
|
|
2017
Q3 | $3.88M | Buy |
63,488
+5,513
| +10% | +$334K | 0.87% | 46 |
|
|
2017
Q2 | $3.54M | Buy |
57,975
+12,147
| +27% | +$739K | 0.83% | 48 |
|
|
2017
Q1 | $2.78M | Buy |
45,828
+3,654
| +9% | +$222K | 0.65% | 56 |
|
|
2016
Q4 | $2.37M | Buy |
42,174
+993
| +2% | +$58.1K | 0.58% | 59 |
|
|
2016
Q3 | $2.45M | Sell |
41,181
-12,653
| -24% | -$740K | 0.65% | 54 |
|
|
2016
Q2 | $2.96M | Buy |
53,834
+4,285
| +9% | +$228K | 0.76% | 48 |
|
|
2016
Q1 | $2.5M | Buy |
49,549
+3,363
| +7% | +$165K | 0.64% | 50 |
|
|
2015
Q4 | $2.33M | Buy |
46,186
+12,543
| +37% | +$632K | 0.58% | 52 |
|
|
2015
Q3 | $1.59M | Buy |
33,643
+8,166
| +32% | +$434K | 0.42% | 57 |
|
|
2015
Q2 | $1.38M | Buy |
25,477
+919
| +4% | +$51.5K | 0.34% | 66 |
|
|
2015
Q1 | $1.35M | Buy |
24,558
+8,624
| +54% | +$488K | 0.34% | 61 |
|
|
2014
Q4 | $863K | Buy |
15,934
+5,753
| +57% | +$321K | 0.23% | 67 |
|
|
2014
Q3 | $576K | Buy |
10,181
+419
| +4% | +$23.5K | 0.17% | 74 |
|
|
2014
Q2 | $539K | Buy |
9,762
+838
| +9% | +$45.7K | 0.16% | 72 |
|
|
2014
Q1 | $483K | Buy |
8,924
+4,077
| +84% | +$211K | 0.16% | 75 |
|
|
2013
Q4 | $231K | Buy |
4,847
+314
| +7% | +$14.4K | 0.08% | 91 |
|
|
2013
Q3 | $206K | Buy |
4,533
+236
| +5% | +$10.8K | 0.08% | 93 |
|
|
2013
Q2 | $190K | Buy |
+4,297
| New | +$192K | 0.08% | 102 |
|
Other funds holding MRK
Kings Point Capital Management's MRK Position: Q1 2022 in Review
Kings Point Capital Management increased its Merck (MRK) stake by 1.6% in Q1 2022, buying an estimated $14.3K and bringing the position to 11,710 shares worth $961K. The position accounts for 0.08% of the portfolio, ranked #104.
Kings Point Capital Management first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. The position peaked at $3.88M in Q3 2017. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.
- Kings Point Capital Management held 11,710 shares of Merck worth $961K as of Q1 2022.
- Kings Point Capital Management bought 182 Merck shares in Q1 2022, an estimated $14.3K.
- Merck made up 0.08% of Kings Point Capital Management's portfolio in Q1 2022, its #104 holding.
- Kings Point Capital Management first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
- Kings Point Capital Management's Merck position peaked at $3.88M in Q3 2017.
- 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.
Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.